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Abstract
During mammalian testis development distinct generations of fetal and adult Leydig cells arise.
Luteinising hormone (LH) is required for normal adult Leydig cell function and for the
establishment of normal adult Leydig cell number but its role in the process of adult Leydig cell
differentiation has remained uncertain. In this study we have examined adult Leydig cell
differentiation in gonadotrophin-releasing hormone (GnRH)-null mice which are deficient in
circulating gonadotrophins. Adult Leydig cell differentiation was assessed by measuring expression
of mRNA species encoding four specific markers of adult Leydig cell differentiation in the mouse.
Each of these markers (3β-hydroxysteroid dehydrogenase type VI (3βHSD VI), 17β-
hydroxysteroid dehydrogenase type III (17βHSD III), prostaglandin D (PGD)-synthetase and
oestrogen sulphotransferase (EST)) is expressed only in the adult Leydig cell lineage in the normal
adult animal. Real-time PCR studies showed that all four markers are expressed in adult GnRH-null
mice. Localisation of 3βHSD VI and PGD-synthetase expression by in situ hybridisation confirmed
that these genes are expressed in the interstitial tissue of the GnRH-null mouse. Treatment of
animals with human chorionic gonadotrophin increased expression of 3βHSD VI and 17βHSD III
within 12 hours further indicating that differentiated, but unstimulated cells already exist in the
GnRH-null mouse. Thus, while previous studies have shown that LH is required for adult Leydig
cell proliferation and activity, results from the present study show that adult Leydig cell
differentiation will take place in animals deficient in LH.
Background
In mice, as in most mammalian species, two generations
of Leydig cells arise during normal testis development. A
"fetal" population which appears shortly after testis differ-
entiation in utero and an "adult" population which arises
after birth around day 7 [1–3]. Morphological and func-
tional maturation of the adult Leydig cells is critically de-
pendent on luteinising hormone (LH) stimulation and
this is clearly seen in mice lacking either circulating LH or
the LH-receptor [4–7]. In these animals Leydig cell
number fails to develop normally after birth and circulat-
ing androgen levels are low or undetectable [6–9]. In con-
trast, testicular androgen levels and Leydig cell number is
normal during fetal development in animals lacking go-
nadotrophins [8,9] showing that the fetal population of
Leydig cells does not require gonadotrophins during this
period. Despite the clear role for LH in proliferation and
maturation of adult Leydig cells in the postnatal testis, it
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is not known whether this hormone is essential for the on-
set of adult Leydig cell differentiation. Early studies sug-
gested that LH is required for the differentiation process
[10–12] while more recent, immunohistochemical stud-
ies have reported that specific steroidogenic enzymes are
detectable in rat adult Leydig cell precursors before LH-re-
ceptors are detectable [13]. This evidence would suggest
that Leydig cell differentiation begins in the absence of
LH-stimulation although it remains possible that low, un-
detectable levels of receptor are present prior to differenti-
ation. Certainly, Leydig cell precursor cells express the LH-
receptor gene prior to apparent differentiation although it
is not clear whether transcripts are translated or produce
functional protein [14–16].
It has been shown previously that in the mouse mRNA
species encoding 3β-hydroxysteroid dehydrogenase type
VI (3βHSD VI), 17β-hydroxysteroid dehydrogenase type
III (17βHSD III), prostaglandin (PG) D-synthetase, estro-
gen sulfotransferase (EST) and vascular cell adhesion mol-
ecule 1 (VCAM 1) are expressed only in the adult Leydig
cell population and not in the fetal population [1,17–20].
It is possible, therefore, to use these markers to examine
the role of LH in the initiation of adult Leydig cell differ-
entiation using mice which lack gonadotrophin-stimula-
tion. Expression of these markers in mice lacking
gonadotrophins would be a clear demonstration that Ley-
dig cell differentiation does not require LH stimulation. It
would be anticipated, however, that even if adult Leydig
cells exist in the absence of LH-stimulation the expression
of these specific markers will be very low or non-existant
since overall Leydig cell activity is determined by LH [21].
Treatment of gonadotrophin-deficient mice with hCG is
likely, however, to lead to a rapid increase in expression of
markers within 24 hours if adult Leydig cells already exist.
If the cells have not differentiated then a more prolonged
period of treatment is likely to be required to induce dif-
ferentiation of Leydig cells and expression of markers. For
these reasons the expression of adult Leydig cell markers
has been examined in the gonadotrophin-deficient gona-
dotrophin-releasing hormone (GnRH)-null (hpg) mouse.
This animal has an advantage over receptor-deficient
models in that the gonads remain responsive to exoge-
nous hormone treatment.
Materials and Methods
Animals and treatments
Normal and GnRH-null mice were maintained at the Uni-
versity of Glasgow and at the University of Oxford under
UK Home Office regulations as previously described [8].
Adult animals (greater than 2 months) (four per group)
were used without treatment or after sub-cutaneous injec-
tions of recombinant hCG (4IU/injection in saline) (Sero-
no Pharmaceutials Ltd, Feltham, Middlesex, UK). The
injections were given every 12 hours and animals were
killed 2 hour after the final injection. The testes were fro-
zen in liquid N2 or fixed overnight in Bouin's fluid before
being stored in 70% ethanol.
Reverse transcription and Real-time PCR
For quantification of the testicular content of specific
mRNA species a real-time PCR approach was used which
utilised the TaqMan PCR method following reverse tran-
scription of the isolated RNA [22]. To allow specific
mRNA levels to be expressed per testis and to control for
the efficiency of RNA extraction, RNA degradation and the
reverse transcription step an external standard was used
[18]. The external standard was luciferase mRNA (Prome-
ga UK, Southampton, UK) and 5 ng was added to each tes-
tis at the start of the RNA extraction procedure. Testis RNA
was extracted using Trizol (Life Technologies, Paisley, UK)
and residual genomic DNA was removed by DNAse treat-
ment (DNA-free, Ambion Inc, supplied by AMS biotech-
nology, UK). The RNA was reverse transcribed using
random hexamers and Moloney murine leukemia virus
reverse transcriptase (Superscript II, Life Technologies,
UK) as described previously [23,24].
Primers and probes for use in the TaqMan method have
been described previously [19]. The real-time PCRs were
carried out in a 25 µl volume using a 96-well plate format.
Components for real-time PCR were purchased from Ap-
plied Biosystems (Warrington, UK) apart from primers
and probes which came from MWG Biotech (Milton Key-
nes, UK). Each PCR well contained reaction buffer, 5 mM
MgCl2, 200 µM dNTPs (including dUTP), 300 nM each
primer, 200 nM probe and 0.02 U/µl enzyme (Amplitaq
Gold). Reactions were carried out and fluorescence detect-
ed on a GeneAmp 5700 system (Applied Biosystems, War-
rington, Cheshire, UK). For each sample a replicate was
run omitting the reverse transcription step and a template
negative control was run for each primer/probe combina-
tion. The quantity of each measured cDNA was then ex-
pressed relative to the internal standard luciferase cDNA
in the same sample. This method allows direct compari-
son of expression levels per testis between different sam-
ples [18].
In situ hybridisation and histology
Testes from adult GnRH-null mice and GnRH-null mice
treated with hCG were fixed in Bouins and prepared for in
situ  hybridisation as described previously [1]. In situ
probes for 3βHSD type VI and PGD-synthetase were pro-
duced as described previously [1,18]. Sense and antisense
cRNA probes were prepared using T3 and T7 polymerase
and were labelled with [35S]dUTP. Tissue sections (7 µm
and at least four sections per animal) were hybridised
overnight at 60°C with probe (100,000 c.p.m./µL) in hy-
bridisation buffer (50% deionized formamide, 10% dex-
tran sulphate, 50 mM dithiothreitol, 500 µg/mL DNAReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/4
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from calf thymus, 1 × Denhardt's solution, 20 mM Tris/
HCl, pH8.0, 5 mM EDTA, 10 mM sodium phosphate, pH
6.8). Following hybridisation, slides were washed, dehy-
drated and allowed to air dry. Autoradiography was car-
ried out using Ilford K5 emulsion (Ilford, Cheshire, UK)
and the slides were stained with Mayer's haematoxylin
and eosin (Merck Ltd, Leicestershire, UK).
To generate semi-thin (1 µm) sections for histology testes
were fixed in 1% glutaraldehyde-4% paraformaldehyde,
in phosphate buffer (0.1 M), pH 7.2 for 24 h at 4°C and
embedded in araldite. Cut sections were stained with tolu-
idine blue.
Statistical analysis
To examine the effects of hCG injection on Leydig cell
gene expression data from two experiments were normal-
ised and combined. Differences between groups was ana-
lysed by single factor analysis of variance of log-
transformed data. Differences beween means was deter-
mined using the Newman-Keul post-test.
Results
Leydig cell morphology in adult GnRH-null mice
Leydig cells in adult GnRH-null mice were characterised
by the presence of numerous large lipid droplets dispersed
through the cell (Fig 1A). In normal adult mice the Leydig
cells also frequently contained lipid droplets although
these were generally smaller than in the GnRH-null mice
(Fig 1B). In normal neonatal testes which contain only fe-
tal-type Leydig cells there was more variation in Leydig
cell morphology with lipid droplets present in many cells
in characteristics clusters (Fig 1C). Some Leydig cells in
the neonatal testis did not appear to contain lipid droplets
although using semi-thin sections it is possible that they
are present in the cell but not in the section shown.
Expression of adult Leydig cell markers in GnRH-null mice
A comparison of the expression of Leydig cell-specific
mRNA species in GnRH-null mice and normal mice is
shown in Table 1. Results are expressed relative to an ex-
ternal standard (luciferase) which was added to all testes
at the RNA extraction phase and results are, therefore,
comparable on a per testis basis [18]. The number of Ley-
dig cells in the adult GnRH-null mouse testis is 10% of
adult normal [9] and in the final column of Table 1 levels
of mRNA are expressed relative to adult normal and cor-
rected for cell number. Data from neonatal normal ani-
mals is included for control purposes since they contain
only fetal-type Leydig cells [1,2]. The results show that, of
those mRNA species tested, two (glutathione-S-transferase
(GST) 5–5 and 3βHSD type I) are expressed at adult nor-
mal levels in the GnRH-null testis while the rest show a
markedly reduced level of expression. There is, however,
considerable variation with cytochrome P450 side chain
cleavage (P450scc), 3βHSD VI and PGD-synthetase
present at less than 1% of normal while epoxide hydrolase
(EH) is nearly 20% of normal. The four markers of adult
Leydig cell differentiation which were measured in this
study (3βHSD VI, PGD-synthetase, EST and 17βHSD III)
were all detectable in the adult GnRH-null testis although
expressions levels were amongst the lowest for all mRNA
species measured. In most cases expression levels of
mRNA species in adult GnRH-null animals was similar to,
or higher than, that in neonatal normal animals. The ex-
ceptions were P450scc and renin. As expected 3βHSD VI
and EST levels were undetectable in neonatal normal ani-
mals while the relatively high levels of PGD-synthetase
and 17βHSD III in these animals is due expression in the
seminiferous tubules [17,25].
Effect of hCG injections on marker expression in GnRH-
null mice
Injection of adult GnRH-null mice with hCG increased
the levels of all mRNA species tested with the exception of
3βHSD I which showed no change under the injection re-
gime used (Fig 1). A single injection of hCG was sufficient
to increase significantly levels of mRNA encoding
P450c17, P450scc and steroidogenic acute regulatory
(StAR) protein while two injections, spaced over 12 hours,
increased expression of 3βHSD VI and 17βHSD III. Levels
of EST, PGD-synthetase and relaxin-like factor (RLF) did
not increase significantly until after four injections. The
biggest change in expression was seen in 3βHSD VI which
showed a 191-fold increase over control after 4 injections.
In situ hybridisation
In situ hybridisation was used to localise expression of
markers of adult Leydig cell differentiation in the GnRH-
null testis. A probe for 3βHSD VI showed specific localisa-
tion to the interstitial tissue in untreated GnRH-null mice
(Fig 2A, 2B) with a clear increase in expression after hCG
treatment (Fig 2C). Hybridisation of the 3βHSD VI probe
tended to be in the central interstitial tissue rather than in
the peritubular region (Fig 2B). A probe for PGD-syn-
thetase also showed localisation to the interstitial tissue in
untreated GnRH-null mice (Fig 2E) although there was no
clear change in expression after hCG treatment (not
shown).
Discussion
The initial studies which identified fetal and adult Leydig
cells as belonging to different cell populations were based
on morphological differences between the two cell types
[26,27]. These differences are not particularly suitable,
however, for differentiating between fetal and adult cells
under conditions of hormonal or growth-factor depriva-
tion since the morphology itself will be affected by the
state of deprivation. This is clearly seen in the present
study, and in previous studies [4,9,28], which show thatReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/4
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Leydig cells in GnRH-null mice contain numerous large li-
pid droplets which are unlike either normal fetal or adult
Leydig cells but are similar to Leydig cells with significant-
ly reduced levels of steroidogenesis [29]. It is worth not-
ing, however, that lipid droplet distribution in the GnRH-
null adult Leydig cell is similar to that of the normal adult
Leydig cell although the lipid droplets are larger and more
frequent. Lipid droplet distribution in adult GnRH-null
mice is unlike the characteristic clusters seen in fetal Ley-
dig cells.
While morphological markers are clearly not ideal for
identifying fetal and adult Leydig cells other studies have
now shown that there are fundamental differences in gene
expression between the two Leydig cell populations which
could be used to differentiate between the cell types. In in-
itial studies it was shown that 11β-hydroxysteroid dehy-
drogenase type 1 (11βHSD1) is expressed in the adult
Leydig cells of the rat but that there is no expression in fe-
tal cells [30,31]. Our group and others have extended this
to identify four mRNA species (3βHSD VI, EST, PGD-syn-
thetase and 17βHSD III) which are expressed in the adult
Leydig cells, but not the fetal Leydig cells, of the mouse
[17–20]. So far, the only clearly identified differences in
gene expression between the two populations are for
genes expressed in the adult cell population but not in the
Figure 1
Light micrographs showing Leydig cell morphology in adult hpg testes (A), adult normal testes (B) and neonatal (day 7) testes 
(C). On micrographs A and C the bar represents 10 µm while on B it represent 20 µm.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/4
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Figure 2
Expression of Leydig cell-specific mRNA species in testes of GnRH-null mice following injection of hCG. Levels of mRNA were 
measured by real-time PCR. Results show expression of each mRNA species following 1, 2 or 4 injections of hCG spaced 12 
hours apart. The results for each mRNA species are expressed relative to control (untreated) GnRH-null animals. In each 
group the mean ± SEM of four animals is shown. Groups with different letter superscripts are significantly (P < 0.05) different.
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fetal population [1,17–19]. Genes which are highly ex-
pressed in the fetal Leydig cell population, such as those
encoding renin and thrombospondin 2, continue to be
expressed in the adult testis, albeit at low levels
[19,32,33]. This may be because adult Leydig cells express
these genes at low levels or, more likely, because the fetal
Leydig cell population persists in the adult testis [19,34–
36]. Identification of genes specifically expressed in the
adult Leydig cell population but not the fetal Leydig cell
population does, however, allow us to determine whether
adult Leydig cells develop in the absence of specific hor-
mones or growth factors.
Normal differentiation of the adult Leydig cell population
in the mouse begins around postnatal day 7 [1–3]. It has
been shown previously that in the absence of LH there is
a failure of normal proliferation of these cells and devel-
opment of normal steroidogenic function does not occur
[8,9]. Thus, there is no doubt that once differentiation has
started adult Leydig cells require LH-stimulation but the
role of LH at the onset of the initial differentiation phase
has remained uncertain. Results from this study now
show, however, that adult Leydig cells will differentiate in
mice deficient in circulating LH. This conclusion is based
primarily on the measured expression of specific adult
Leydig cell markers in the testes of untreated GnRH-null
mice. Expression of all four markers of adult Leydig cell
differentiation was low but clearly detectable by real-time
PCR in adult GnRH-null mice. Localisation, by in situ hy-
bridisation, of two of these markers confirmed that ex-
pression was present in the untreated GnRH-null mouse
testis and was localised to the interstitial tissue. For this
data to be accepted as clear evidence that adult Leydig cells
differentiate despite a deficiency of LH depends on the ve-
racity of the markers chosen to indicate adult Leydig cell
development. Evidence that these markers are specific to
adult Leydig cells comes from previous studies which have
shown that during development in normal mice mRNA
species encoding 3βHSD VI and EST are undetectable by
real-time PCR [19] [and confirmed by current studies], in
situ  hybridisation [1], immunohistochemistry [20] or
Northern blotting [20] before adult Leydig cell differenti-
ation occurs. In addition, while both PDG-synthetase and
17βHSD III are expressed in the fetal/neonatal testis, this
expression is only in the seminiferous tubules and stops
prior to puberty at which time expression appears in the
adult Leydig cell population [17,18]. Expression of PGD-
synthetase in the current experiments was confirmed by in
situ hybridisation to be localised to the interstitial tissue of
the adult GnRH-null mouse testis. Thus, as far as can be
determined, the markers used are specific for the adult
Leydig cell population and indicate that these cells are
present in the GnRH-null testis.
Comparison of expression patterns in adult GnRH-null
testes with normal neonatal testes is also informative. If
adult GnRH-null testes do not contain adult Leydig cells
and have only fetal-type Leydig cells present it would be
expected that the general pattern of mRNA expression
would be that of a neonatal testis lacking gonadotrophin
support. In fact, with the exceptions of P450scc and renin,
expression levels are similar or higher in the adult GnRH-
null testis. This is consistent, therefore, with differentia-
Table 1: 
Gene Expression per testis (relative to Luciferase × 103) GnRH-null relative to adult 
normal (corrected for cell 
number)2
Adult GnRH-null Adult normal Neonatal normal1
P450scc 0.23 ± 0.04 242 ± 35 2.2 ± 0.5 0.95%
P450c17 15.3 ± 1.8 3453 ± 1042 13.5 ± 3.5 4.4%
GST5-5 60.6 ± 5.6 677 ± 91 76 ± 15 89.5%
RLF 19.2 ± 2.1 2490 ± 611 5.3 ± 1.3 7.7%
3βHSD I 7.5 ± 1.7 51 ± 10 4.6 ± 1.8 147.0%
Renin 0.027 ± 0.012 21.4 ± 3.5 5.8 ± 0.9 1.3%
EH 18.5 ± 1.6 996 ± 112 8.0 ± 1.6 18.5%
StAR 2.08 ± 0.2 177 ± 30 4.0 ± 1.1 11.7%
3βHSD VI* 0.014 ± 0.005 124 ± 15 ND3 0.11%
PGD-synthetase* 0.26 ± 0.06 843 ± 43 2.5 ± 1.1 0.31%
EST* 0.014 ± 0.009 9.0 ± 2.4 ND3 1.5%
17βHSD III* 2.39 ± 0.21 1644 ± 192 140 ± 7 1.45%
* Genes expressed in adult Leydig cells but not fetal Leydig cells 1Neonatal animals were 5 days old. 2 Expression in GnRH-null mice is expressed as 
a percentage of normal mice and corrected for reduced Leydig cell number in GnRH-null animals [4]. 3ND = not detectable.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/4
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Figure 3
In situ hybridization studies showing 3β-hydroxysteroid dehydrogenase (3βHSD) type VI and prostaglandin D (PGD)-syn-
thetase expression in adult control GnRH-null mice and GnRH-null mice following injection with hCG. Hybridisation of 3βHSD 
VI anti-sense probe to control GnRH-null testis is shown in A) and at higher power in B). In C) hybridisation to testes from 
GnRH-null mice after 4 injections of hCG is shown. Hybridisation to a sense 3βHSD VI probe is shown in D). Hybridisation of 
an anti-sense PGD-synthetase probe to testis from control GnRH-null mice is shown in E) while hybridization of a sense probe 
is shown in F).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/4
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tion of an adult population of cells in the adult GnRH-
null testis.
The effects of hCG treatment on gene expression in the
adult GnRH-null mouse testis also supports the hypothe-
sis that adult Leydig cells are present in this animal. Ex-
pression of the markers 3βHSD VI and 17βHSD III was
increased significantly after 2 injections of hCG within a
12 hour period. During normal testicular development
there is a gap of at least four days between initial Leydig
cell differentiation [around day 7 [2]] and first expression
of 3βHSD VI mRNA (around day 11 [1]) and a longer gap
before the first significant rise in 17βHSD III mRNA levels
(after day 20 [19]). If only undifferentiated precursor cells
were present in the GnRH-null testis it is likely that a more
prolonged period of hCG treatment would be required
before increased expression of 3βHSD VI and 17βHSD III
would be seen. In contrast to 3βHSD VI and 17βHSD III
expression of mRNA species encoding EST and PGD did
not increase until after 48 hours of hCG treatment. This is
consistent with previous data which has shown that these
two genes exhibit a delayed pattern of expression during
normal development [19].
In the GnRH-null mouse lack of pituitary stimulation by
GnRH causes a marked reduction in pituitary synthesis
and release of gonadotrophins [8]. This means that circu-
lating levels of LH and FSH are very low but they are not,
necessarily, abolished. Thus, the possibility cannot be ex-
cluded that there is low-level gonadotrophin-stimulation
of Leydig cell precursors. It should be noted, however, that
intratesticular testosterone levels in GnRH-null mice are
undetectable and are lower than in LH-receptor-null mice
[6,7]. Any circulating LH must, therefore, be at a minimal
level and, as such, is unlikely to affect Leydig cell
development.
If, as data described here would suggest, adult Leydig cells
develop without LH-stimulation this begs the question as
to what state of differentiation/development the cells
reach. Morphological and functional development of the
adult Leydig cell lineage has recently been reviewed by
Mendis-Handagama & Ariyaratne [37]. Spindle-shaped,
Leydig precursor cells are found in the peritubular region
of the interstitial tissue and differentiate initially to pro-
genitor cells in the same region. Further development to
"newly formed" and "immature" adult Leydig cells is as-
sociated with rounding of the cells and movement to the
central interstitial region [37]. The expression of adult
Leydig cell genes in the unstimulated GnRH-null testis
and the rapid response of some of these to hCG stimula-
tion suggests that the cells have moved beyond initial
steps of differentiation and may represent a form of un-
stimulated, immature adult cell. Further evidence that the
cells have moved beyond the progenitor stage is provided
by the 3βHSD VI in situ hybridisation studies which show
that the hybridisation signal is localised primarily in the
central interstitial tissue area rather than the peritubular
region where the progenitor cells are located. It is also in-
teresting to note that the total number of morphological-
ly-recognisable Leydig cells (with no distinction drawn
between fetal and adult cells) actually doubles over the
pubertal period in the GnRH-null animal [9]. This would
be consistent with morphological differentiation of adult
Leydig cells during this period in GnRH-null mice and ties
in with the functional data described above.
Despite apparent adult Leydig cell differentiation in
GnRH-null mice the total number of Leydig cells in these
animals remains markedly reduced at about 10% of con-
trol [9]. It is clear that development of the final number of
adult Leydig cells is a combination of precursor differenti-
ation and proliferation of the mature cell although the rel-
ative contribution of the two processes remains unclear
[37]. If it is accepted, from the data presented here, that
Leydig cell differentiation is largely an LH-independent
event the marked reduction in Leydig cell number in the
GnRH-null mouse would be consistent with a reduced
role for cell differentiation and a more important role for
proliferation in determining final cell number. A further
implication of this model would be that while differenti-
ation is an LH-independent event cell proliferation (in-
cluding precursor/progenitor proliferation) is LH-
dependent. This would be consistent with earlier studies
showing that LH will induce Leydig cell proliferation in
GnRH-null mice [28].
Results from this study suggest that adult Leydig cell dif-
ferentiation does not require LH although the hormone is
necessary for functional development of the cells and for
the establishment of normal cell number. The initial stim-
ulus for adult Leydig cell differentiation remains un-
known although thyroid stimulating hormone appears to
be required [30,38] along with the Sertoli cell products
Dhh and PDGF-A [35,39]. Whatever other factor or fac-
tors are involved it appears likely that at least some will be
of Sertoli cell origin since these cells are closely involved
in regulation of the Leydig cells and are necessary for Ley-
dig cell survival and function [40]
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